Christian Möbs
Möbs, Christian
VIAF ID: 159033411 (Personal)
Permalink: http://viaf.org/viaf/159033411
Preferred Forms
- 100 0 _ ‡a Christian Möbs
- 100 1 _ ‡a Möbs, Christian
- 100 1 _ ‡a Möbs, Christian
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
6th International Symposium on Molecular Allergology (ISMA). | |
7th Drug hypersensitivity meeting: part two. | |
Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells | |
Birch pollen allergen-specific immunotherapy with glutaraldehyde-modified allergoid induces IL-10 secretion and protective antibody responses | |
Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation | |
Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model. | |
CD3-positive B cells: a storage-dependent phenomenon | |
Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy. | |
Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris | |
Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy | |
[Diagnostics of drug hypersensitivity reactions]. | |
The diversity of Bet v 1–specific IgG 4 antibodies remains mostly constant during the course of birch pollen immunotherapy | |
Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria. | |
honey bee venom allergen Api m 10 displays one major IgE epitope, Api m 10 160‐174 | |
Immunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding. | |
Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects. | |
Influenza-derived peptides cross-react with allergens and provide asthma protection. | |
Monitoring the epitope recognition profiles of IgE, IgG 1 , and IgG 4 during birch pollen immunotherapy | |
Research Techniques Made Simple: Monitoring of T-Cell Subsets using the ELISPOT Assay. | |
Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions. | |
Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. | |
Structure of intact IgE and the mechanism of ligelizumab revealed by electron microscopy | |
T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita. | |
Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction. | |
Zelluläre Mechanismen der Toleranzinduktion unter spezifischer Immuntherapie mit inhalativen Allergenen |